Home > PS Ratio > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of JAGSONPAL PHARMACEUTICALS is 6.31.

Share Price ₹240.9Jan 29,2025
Market Cap ₹1,599.2 Cr
Sales-TTM₹253.6 CrTTM-Standalone Results
Price/Sales6.31xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of JAGSONPAL PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of JAGSONPAL PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹1,599.2 Cr] as on Jan 29,2025

(/) Sales [ ₹253.6 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 6.31x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay '6.31 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of JAGSONPAL PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of JAGSONPAL PHARMACEUTICALS


PS Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS

- JAGSONPAL PHARMACEUTICALS 's latest p/e ratio is 6.31x.

- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.39x.

- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 3.21x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 3.78x.

- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.29x.


How does JAGSONPAL PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
JAGSONPAL PHARMACEUTICALS 253.66.311,599.2
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.28416,692.0
CIPLA LTD26,981.24.26115,000.0
DR REDDYS LABORATORIES LTD31,229.33.1698,616.4
ZYDUS LIFESCIENCES LTD21,483.54.3793,841.4
DIVIS LABORATORIES LTD8,614.017.32149,215.0
MANKIND PHARMA LTD11,641.08.78102,232.0
TORRENT PHARMACEUTICALS LTD11,302.010.06113,701.0
LUPIN LTD21,431.34.4094,337.9
AUROBINDO PHARMA LTD30,295.02.2267,192.9
ABBOTT INDIA LTD6,066.18.9254,136.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JAGSONPAL PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.22x
Max industry PS 17.32x
Median industry PS 6.31x
Average industry PS 7.10x



You may also like the below Video Courses